ATM
ATM (At-The-Market Offering) is a type of equity issuance where a publicly traded company sells newly issued shares directly into the open market over time, at prevailing market prices, rather than all at once at a fixed price.
Think of it as a “drip-feed” stock sale – the company can gradually sell shares when market conditions are favorable, raising capital more flexibly than through a traditional secondary offering.
Why ATM Offerings Matter in Stock Analysis:
- Flexible Capital Raising:
Allows companies to raise funds opportunistically, taking advantage of strong market demand without committing to a single large sale. - Reduced Dilution Shock:
Because shares are sold incrementally, the immediate dilution to existing shareholders is often less noticeable, though over time, it can still be significant. - Market Timing Advantage:
Companies can slow or pause share sales if prices fall, or accelerate them when prices are high, improving potential proceeds. - Cost Efficiency:
ATMs generally involve lower underwriting fees compared to traditional equity offerings, preserving more capital for company use. - Impact on Share Price:
While gradual, ATM programs can still apply downward pressure on share prices if investors anticipate increased supply.
Practical Example:
Biotech firms often use ATM offerings to fund ongoing clinical trials. For instance, a small-cap biotech might set up a $200M ATM program and sell shares periodically as positive trial news lifts the stock price, ensuring they raise capital at more favorable valuations.
Bottom Line:
ATM offerings give companies a nimble, cost-effective way to raise capital, but investors need to watch for long-term dilution and its potential drag on share performance.